Outer membrane vesicles enhance tau phosphorylation and contribute to cognitive impairment
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Outer membrane vesicles (OMVs) are nanosized vesicles produced by the gut microbiota (GM). The GM is well‐known to be involved in the pathological process of Alzheimer's disease (AD). However, the mechanism of OMVs is not clear. In the present study, we demonstrated the involvement of OMVs in the development of cognitive (learning and memory) dysfunction induced by blood–brain barrier (BBB) disruption. More important, further study showed that OMVs induced tau phosphorylation by activating glycogen synthase kinase 3β (GSK‐3β) in the hippocampus. OMVs activated astrocytes and microglia, increased secretion of inflammatory cytokines (nuclear factor κB, interleukin‐1β, and tumour necrosis factor‐α) in the hippocampus. Therefore, OMVs increase the permeability of the BBB and promote the activation of astrocytes and microglia, inducing an inflammatory response and tau hyperphosphorylation by activating the GSK‐3β pathway and finally leading to cognitive impairment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Vorhees, C. V., & Williams, M. T. (2006) · Nature Protocols · doi:10.1038/nprot.2006.116 · Cited by 4,629 · cited 1×
“Previous studies have revealed that the GM regulates the micromorphology of the brain and behaviour (Lu et al., 2018; Qin et al., 2019; Vorhees & Williams, 2006).”
ResultScheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
The gut microbiota influences blood-brain barrier permeability in mice
Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Bakocevic, N., Ng, L. G., Kundu, P., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009759 · Cited by 2,530
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137
Neuroinflammation in Alzheimer's disease: current evidence and future directions
Calsolaro, V., & Edison, P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.010 · Cited by 1,726 · cited 1×
“…pathway is well‐documented as a critical signalling pathway that affects neuroinflammation (Golpich et al., 2015) and tau hyperphosphorylation (Cai, Zhao, & Zhao, 2012), which play important roles in the cognitive dysfunction associated with AD (Calsolaro & Edison, 2016; Scheltens et al., 2016).”
BackgroundThe interplay between the intestinal microbiota and the brain
Collins, S. M., Surette, M., & Bercik, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2876 · Cited by 1,611
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901 · cited 1×
“GM from SPF AD mice deteriorates the Aβ pathology of germ‐free AD mice (Harach et al., 2017), proving that the GM is involved in the development of AD.”
BackgroundThe Gut Microbiota and Alzheimer’s Disease
Jiang, C., Li, G., Huang, P., Liu, Z., & Zhao, B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161141 · Cited by 852
Self-citationBrain-Gut-Microbiota Axis in Alzheimer’s Disease
Kowalski, K., & Mulak, A. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18087 · Cited by 826 · cited 1×
“Recent research techniques and results focused on the interac- tion of the gut microbiota (GM) with the central nervous system (“microbe‐gut‐brain axis”) (Kowalski & Mulak, 2019; Roubalova et al., 2019), and AD has been associated with an abnormal GM composition (Bostanciklioğlu, 2019; Doulberis et…”
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804 · cited 4×
“Several studies have demonstrated that the GM and its metabolites are involved in the metabolic process of neurodegenerative diseases (Quigley, 2017; Tse, 2017).”
BackgroundInfluentialWalker, D. G., & Lue, L.-F. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0139-9 · Cited by 562 · cited 1×
“…is the main pathological factor of AD, leading to tau protein phosphorylation, blood–brain barrier destruction, neuronal death, synapse loss, demyelination and other pathological changes in AD (Buford, 2017; Latta, Brothers, &Wilcock, 2015; Minter, Taylor, & Crack, 2016; Walker & Lue, 2015).”
BackgroundThe Gut–Brain Axis and the Microbiome: Mechanisms and Clinical Implications
Osadchiy, V., Martin, C. R., & Mayer, E. A. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.10.002 · Cited by 555
Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease
Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., & Battino, M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw023 · Cited by 496 · cited 2×
“We (Jiang, Li, Huang, Liu, & Zhao, 2017) and others (Alkasir, Li, Li, Jin, & Zhu, 2017; Hu, Wang, & Jin, 2016; Mancuso & Santangelo, 2018; Pistollato et al., 2016; Quigley, 2017; Zhang et al., 2017) have proposed that the trigger for pathogenic factors in AD patients is the GM. OMVs derived from…”
BackgroundThe contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
Minter, M. R., Taylor, J. M., & Crack, P. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13411 · Cited by 451
Altered Gut Microbiota in a Mouse Model of Alzheimer’s Disease
Zhang, L., Wang, Y., Xiayu, X., Shi, C., Chen, W., Song, N., Fu, X., Zhou, R., Xu, Y.-F., Huang, L., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170020 · Cited by 449
(Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease
Buford, T. W. (2017) · Microbiome · doi:10.1186/s40168-017-0296-0 · Cited by 409 · cited 2×
“…is the main pathological factor of AD, leading to tau protein phosphorylation, blood–brain barrier destruction, neuronal death, synapse loss, demyelination and other pathological changes in AD (Buford, 2017; Latta, Brothers, &Wilcock, 2015; Minter, Taylor, & Crack, 2016; Walker & Lue, 2015).”
BackgroundLyte, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003726 · Cited by 399 · cited 1×
“When the BBB has high permeability, β‐amyloid deposition, inflammatory factor activation and other specific AD pathophysiological changes occur (Lyte, 2013).”
BackgroundZhao, Y., Jaber, V., & Lukiw, W. J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00318 · Cited by 379
Alzheimer’s disease and gut microbiota
Hu, X., Wang, T., & Jin, F. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5083-9 · Cited by 371
Mancuso, C., & Santangelo, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.009 · Cited by 232 · cited 1×
“We (Jiang, Li, Huang, Liu, & Zhao, 2017) and others (Alkasir, Li, Li, Jin, & Zhu, 2017; Hu, Wang, & Jin, 2016; Mancuso & Santangelo, 2018; Pistollato et al., 2016; Quigley, 2017; Zhang et al., 2017) have proposed that the trigger for pathogenic factors in AD patients is the GM. OMVs derived from…”
Cheng, Y., Pardo, M., Armini, R. D. S., Martinez, A., Mouhsine, H., Zagury, J.-F., Jope, R. S., & Beurel, E. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.012 · Cited by 174
The gut microbiome and mental health: implications for anxiety- and trauma-related disorders
Malan-Muller, S., Valles-Colomer, M., Raes, J., Lowry, C. A., Seedat, S., & Hemmings, S. M. J. (2018) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2017.0077 · Cited by 161
Microbiota influence the development of the brain and behaviors in C57BL/6J mice
Lu, J., Synowiec, S., Lu, L., Yu, Y., Bretherick, T., Takada, S., Yarnykh, V., Caplan, J., Caplan, M., Claud, E. C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201829 · Cited by 159 · cited 1×
“Previous studies have revealed that the GM regulates the micromorphology of the brain and behaviour (Lu et al., 2018; Qin et al., 2019; Vorhees & Williams, 2006).”
Result
Cited by
Parker, A., Romano, S., Ansorge, R., Aboelnour, A., Le Gall, G., Savva, G. M., Pontifex, M. G., Telatin, A., Baker, D., Jones, E., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01243-w · Cited by 368
The Impact of Systemic Inflammation on Alzheimer’s Disease Pathology
Xie, J., Van Hoecke, L., & Vandenbroucke, R. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.796867 · Cited by 324
The tremendous biomedical potential of bacterial extracellular vesicles
Xie, J., Li, Q., Haesebrouck, F., Van Hoecke, L., & Vandenbroucke, R. E. (2022) · Trends in Biotechnology · doi:10.1016/j.tibtech.2022.03.005 · Cited by 240
Gong, T., Chen, Q., Mao, H., Zhang, Y., Ren, H., Xu, M., Chen, H., & Yang, D. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.925435 · Cited by 138
Sun, M., Ma, K., Wen, J., Wang, G., Zhang, C., Li, Q., Bao, X., & Wang, H. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190872 · Cited by 113
Metadata
- Authors
- Wei, S., Peng, W., Mai, Y., Li, K., Wei, W., Hu, L., Zhu, S., Zhou, H., Jie, W., Wei, Z., Kang, C., Li, R., Liu, Z., Zhao, B., & Cai, Z.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2019-10-29
- Volume
- 235
- Issue
- 5
- Pages
- 4843-4855
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2982705994
- Cited by
- 120
- References
- 23
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.